![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GHANA OPENS NEW ARV PRODUCTION PLANT
GHANA OPENS NEW ARV PRODUCTION PLANT
September 1, 2005
A new ARVs (antiretrovirals) manufacturing plant has opened in Accra, Ghana, as part of the country's plans to expand local HIV/AIDS drug production. Under Ghanaian law, only the government will be permitted to buy the ARVs, which have met local production standards. Ghana's HIV/AIDS infection rate is estimated at 3.5%.
The West African country's government spends US$6mn per year providing medicines to roughly 2,600 HIV/AIDS patients. However, the new facility -- a joint venture with China's Adams Pharmaceuticals -- is expected to cut costs by 45%.
The UN-administered Global Fund to Fight AIDS, Tuberculosis and Malaria still accounts for the majority of funding for ARVs in Ghana. The fund has spent US$47mn on health projects in the country to date, but is not expected to issue its assessment of the manufacturing project in the short term.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct